Literature DB >> 32223452

Asbestos-related cancers: the 'Hidden Killer' remains a global threat.

Nico van Zandwijk1, Glen Reid2, Arthur L Frank3.   

Abstract

Introduction: Asbestos, the most frequent cause of occupational cancer, continues to be consumed on a massive scale, with millions of people exposed on a daily basis. This review explains why we have failed in curtailing the silent epidemic of asbestos-related disease and why the numbers of asbestos victims are likely to remain high. Emerging and developed countries have to be reminded that asbestos exposure has yet to become a problem of the past. The worldwide spread of asbestos, followed by the surge of asbestos-related cancers, resembles the lung cancer epidemic caused by smoking and stimulated by manufacturers.Areas covered: Underreporting of malignant mesothelioma and asbestos-induced lung cancer, frequently-used arguments in the amphibole/chrysotile debate and the conclusion from bona-fide research organizations, that all forms of asbestos are carcinogenic, are reviewed. Special attention is paid to the consequences of ubiquitous environmental asbestos and the 'changing face' of malignant mesothelioma in countries with heavy asbestos use in the past.Expert opinion: Experts in oncology, respiratory medicine, occupational and public health, and basic researchers must take responsibility and acknowledge the ongoing silent epidemic of asbestos-related diseases. The call for a world-wide asbestos ban is more urgent than ever.

Entities:  

Keywords:  Asbestos; amphibole; chrysotile; lung cancer; malignant mesothelioma

Mesh:

Substances:

Year:  2020        PMID: 32223452     DOI: 10.1080/14737140.2020.1745067

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  4 in total

1.  A potential cause of asbestos-related granulomatosis due to adulterant contamination in a drug abuser.

Authors:  Maria Concetta Lazzaro; Sabrina Romanò; Sergio Santoro; Cristian Camuto; Arnaldo Carbone; Rosario Casamassima; Sergio Abate; Fabio De-Giorgio
Journal:  Virchows Arch       Date:  2020-06-09       Impact factor: 4.064

Review 2.  Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma.

Authors:  Steven G Gray
Journal:  BMC Pulm Med       Date:  2021-05-05       Impact factor: 3.317

Review 3.  Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma.

Authors:  Divya Jain; Yogesh Murti; Wasi Ullah Khan; Rajib Hossain; Mohammad Nabil Hossain; Krishn Kumar Agrawal; Rana Azeem Ashraf; Muhammad Torequl Islam; Pracheta Janmeda; Yasaman Taheri; Mohammed M Alshehri; Sevgi Durna Daştan; Balakyz Yeskaliyeva; Aliya Kipchakbayeva; Javad Sharifi-Rad; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-10-31       Impact factor: 6.543

4.  Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation.

Authors:  Gabriella Serio; Federica Pezzuto; Francesco Fortarezza; Andrea Marzullo; Maria Celeste Delfino; Antonio d'Amati; Daniele Egidio Romano; Sonia Maniglio; Concetta Caporusso; Teresa Lettini; Domenica Cavone; Luigi Vimercati
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.